These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 4599321

  • 1. [Immunology of malignant melanoma].
    Misgeld V.
    Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy].
    Lejeune FJ, Bernheim JL, Vanwijck R.
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract] [Full Text] [Related]

  • 3. [Immunology of melanoma].
    Vanwijck R, Bernheim JL, Lejeune FJ.
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM.
    Wien Klin Wochenschr Suppl; 1979 Mar; 97():3-32. PubMed ID: 106559
    [No Abstract] [Full Text] [Related]

  • 6. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA, Rimoldi D, Liénard D, Carrel S, Lejeune F, Dietrich PY, Cerottini JC, Romero P.
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [Abstract] [Full Text] [Related]

  • 7. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV, Saraeva ZM, Slesareva RI, Monzul' GD.
    Vopr Onkol; 1973 May; 19(3):23-7. PubMed ID: 4762691
    [No Abstract] [Full Text] [Related]

  • 8. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
    Korosteleva TA, Vagner RI, Veresova OV, Potapenkova LS.
    Vopr Onkol; 1983 May; 29(4):38-40. PubMed ID: 6858049
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of advanced malignant melanoma with vaccina oncolysates (author's transl)].
    Wallack MK.
    Nouv Presse Med; 1979 May 26; 8(23):1919-21. PubMed ID: 223123
    [Abstract] [Full Text] [Related]

  • 10. [Future of malignant stage I melanoma. Immunology and immunotherapy].
    Nicolas JF, Berthier O, Trillet-Lenoir V, Claudy A, Revillard JP.
    Ann Dermatol Venereol; 1995 May 26; 122(5):324-35. PubMed ID: 8572476
    [No Abstract] [Full Text] [Related]

  • 11. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV, Korosteleva TA.
    Vopr Onkol; 1975 May 26; 21(4):74-80. PubMed ID: 1105967
    [No Abstract] [Full Text] [Related]

  • 12. [Immunologic reaction-readiness in malignant melanoma].
    Bickhardt R, Kunze J.
    Z Hautkr; 1974 Apr 15; 49(8):315-33. PubMed ID: 4599330
    [No Abstract] [Full Text] [Related]

  • 13. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A, Chen GZ, Wong GY, Liu C, Hirai S, Ferrone S.
    Clin Cancer Res; 1995 Jul 15; 1(7):705-13. PubMed ID: 9816036
    [Abstract] [Full Text] [Related]

  • 14. [Fundamentals and clinic aspects of allergic dermatoses].
    Stüttgen G.
    Allerg Asthmaforsch; 1969 Jul 15; 5():15-227. PubMed ID: 4910875
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW.
    Int Adv Surg Oncol; 1984 Jul 15; 7():241-70. PubMed ID: 6205999
    [Abstract] [Full Text] [Related]

  • 16. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
    Seigler HF, Shingleton WW, Pickrell KL.
    Plast Reconstr Surg; 1975 Mar 15; 55(3):294-8. PubMed ID: 1118487
    [Abstract] [Full Text] [Related]

  • 17. Immunological studies on malignant melanomas of man.
    Romsdahl MM, Cox IS.
    Yale J Biol Med; 1973 Dec 15; 46(5):693-701. PubMed ID: 4205125
    [No Abstract] [Full Text] [Related]

  • 18. [Immunotherapy for melanoma: how can tolerance be overcome?].
    Robert C.
    Ann Dermatol Venereol; 2001 Dec 15; 128(6-7):709-13. PubMed ID: 11460031
    [No Abstract] [Full Text] [Related]

  • 19. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI, Potapenkova LS, Korosteleva TA, Khachaturian LM.
    Vopr Onkol; 1979 Dec 15; 25(4):3-6. PubMed ID: 433214
    [Abstract] [Full Text] [Related]

  • 20. Proceedings: Tumour-specific antigens in melanoma.
    Lewis MG.
    Proc Natl Cancer Conf; 1972 Dec 15; 7():77-83. PubMed ID: 4587663
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.